Related Experiment Video
Updated: Apr 15, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
The generalizability paradox within palliative care clinical trials
Arif H Kamal1, Jeffrey M Peppercorn2
1Division of Medical Oncology and Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA; Center for Learning Health Care, Duke Clinical Research Institute, Durham, NC, USA.
Personalized advanced illness care needs better evidence for diverse patients. Improving evidence generation is crucial for consistent application in complex chronic illness management.
Area of Science:
- Palliative Care
- Evidence-Based Medicine
- Clinical Decision-Making
Background:
- Personalized advanced and chronic illness care demands comprehensive management of supportive needs.
- Current evidence generation may not adequately represent heterogeneous patient populations with complex conditions.
Purpose of the Study:
- To address the challenge of applying generalized research evidence to diverse advanced illness patient populations.
- To explore methods for improving evidence generation for consistent clinical application.
Main Methods:
- Review of current practices in evidence generation for advanced illness care.
- Analysis of limitations in applying generalized evidence to patients with poor performance status, multi-morbidity, and high symptom distress.
Main Results:
- The need for more robust and inclusive evidence generation strategies is highlighted.
- Current evidence bases may lack generalizability for specific patient subgroups.
Conclusions:
- Further research is required to develop evidence generation methods applicable to all patients with advanced disease.
- Enhancing the generalizability of research evidence is critical for effective supportive care.
Related Concept Videos
Ethical Issues
Ethical Concerns in Healthcare:
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Bioequivalence of Drugs: Drugs with Multiple Indications
Bioavailability Study Design: Healthy Subjects Versus Patients
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
